In the study of Gütgemann et al. (30), 98 samples of bile duct tumors were examined for CD56 expression by IHC staining, and they found positive in 4 samples out of 32 cholangiocarcinoma (12.5%). The gene discussed is NCAM1; the disease is cholangiocarcinoma.